962 related articles for article (PubMed ID: 6197163)
1. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
[TBL] [Abstract][Full Text] [Related]
4. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
Baranov V; Yeung MM; Hammarström S
Cancer Res; 1994 Jun; 54(12):3305-14. PubMed ID: 8205554
[TBL] [Abstract][Full Text] [Related]
5. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.
Ilantzis C; Jothy S; Alpert LC; Draber P; Stanners CP
Lab Invest; 1997 May; 76(5):703-16. PubMed ID: 9166289
[TBL] [Abstract][Full Text] [Related]
6. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel tumor-associated Mr 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen.
Shimada S; Ogawa M; Schlom J; Greiner JW
Cancer Res; 1991 Oct; 51(20):5694-703. PubMed ID: 1913687
[TBL] [Abstract][Full Text] [Related]
9. Expression of complementary DNA and genomic clones for carcinoembryonic antigen and nonspecific cross-reacting antigen in Chinese hamster ovary and mouse fibroblast cells and characterization of the membrane-expressed products.
Hefta LJ; Schrewe H; Thompson JA; Oikawa S; Nakazato H; Shively JE
Cancer Res; 1990 Apr; 50(8):2397-403. PubMed ID: 2317824
[TBL] [Abstract][Full Text] [Related]
10. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
Burtin P; Chavanel G; Hendrick JC; Frenoy N
J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
Mulders TM; Bruning PF; Bonfrer JM
Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Arora B; Chhabra A; Yadav MS; Arora DR
Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
[TBL] [Abstract][Full Text] [Related]
14. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
15. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.
Kuroki M; Ichiki S; Kuroki M; Matsuoka Y
J Natl Cancer Inst; 1982 Aug; 69(2):401-8. PubMed ID: 6810002
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
Horoszewicz JS; Kawinski E; Murphy GP
Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
[TBL] [Abstract][Full Text] [Related]
18. Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.
Ferrara RM; Biancardi C; Cavalca V; Botta M; Bailo M; Bartorelli A
Cancer Detect Prev; 1987; 10(1-2):101-8. PubMed ID: 3568003
[TBL] [Abstract][Full Text] [Related]
19. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker.
Kuroki M; Matsushita H; Matsumoto H; Hirose Y; Senba T; Yamamoto T
Anticancer Res; 1999; 19(6C):5599-606. PubMed ID: 10697625
[TBL] [Abstract][Full Text] [Related]
20. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
